RxDoctor Payments Data

Gina Null

Adult Health · Fort Smith, ARNPI 1851614648

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,966 of the $7,851 with a category attached, or 88.7%. It is spread thinly across 52 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,510, 6.9 times the $363 reported in 2021. Among adult health clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,851in general payments, 2019–2025

Across 391 payments — averaging $20.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$815
  • Daiichi Sankyo Inc.$548
  • Incyte Corporation$528
  • AstraZeneca$527
  • Merck$403
  • Eisai Inc.$352
  • plus $5K from 46 others

What the payments were for

  • Food & beverage$6,96689%
  • Education$88611%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,851 in reported general payments places this provider in the 95th percentile of 154 adult health providers in Arkansas.

See all adult health providers in Arkansas

Medicare billing

Part B allowed, 2024
$47,838
Medicare patients
343
Services billed
1,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imatinib Mesylate17$90,979
XareltoRivaroxaban41$24,505
EliquisApixaban22$12,839
Exemestane15$1,564
Anastrozole87$1,320
Letrozole57$1,051
Potassium Chloride23$821
Megestrol Acetate14$647
Levetiracetam11$551
Ondansetron OdtOndansetron31$472
Ondansetron Hcl35$441
Levothyroxine Sodium71$370
Albuterol Sulfate HfaAlbuterol Sulfate18$360
Omeprazole22$326
Tamsulosin Hcl20$312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$267$24,50541 claims
PfizerEliquis$297$12,83922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 154 adult health providers in Arkansas.

Other adult health in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →